ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 677274 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 677274; 2) Community: the network communities that were significantly associated with the response to NSC 677274; 3) Molecule: the relationships between components within communities and NSC 677274; 4) MDR: the compounds that were significantly associated with the NSC 677274.

NSC Compound Enrichment Correlation
NSC 602617 Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 0.0203119150246197 -0.16552294
NSC 618759 4-Penten-3-one, 5,5'-(1,4-phenylenbis)bis[2,2-dimethyl- 1-piperidino-, (E,E)-, dihydrobromide 0.0203119150246197 0.43017299
NSC 625544 Null 0.0203119150246197 0.46157973
NSC 626162 Discorhabdin C . TFA 0.0203119150246197 0.6042919
NSC 627666 1H-Benzo[de]-1,3-benzodioxolo[5,6]quinoline-6a- carbonitrile, 6-benzoyl-1,2-dimethoxy- 0.0203119150246197 -0.1642033
NSC 631136 Benzoxazole, 2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.0203119150246197 0.44791557
NSC 639520 Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0203119150246197 0.551835
NSC 655305 Null 0.0203119150246197 0.49152431
NSC 658143 2-(1-(4-(2-(2-Hydroxyethoxy)ethyl)piperazino))naphthazarin 0.0203119150246197 0.2448409
NSC 668264 Null 0.0203119150246197 0.41423502
Total:80  Current:41    [First] [Prev] [Next] [Last]